These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26176825)

  • 1. Molecular diagnostics identifies risks for graft dysfunction despite borderline histologic changes.
    Hrubá P; Brabcová I; Gueler F; Krejčík Z; Stránecký V; Svobodová E; Malušková J; Gwinner W; Honsová E; Lodererová A; Oberbauer R; Zachoval R; Viklický O
    Kidney Int; 2015 Oct; 88(4):785-95. PubMed ID: 26176825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of Serial Protocol Biopsies Performed After 1 Year in Predicting Long-Term Kidney Allograft Function According to Histologic Phenotype.
    Zachariah MS; Dwivedi AK; Yip CS; Chang SS; Gundroo A; Venuto RC; Tomaszewski J; Patel SK; Sharma R
    Exp Clin Transplant; 2018 Aug; 16(4):391-400. PubMed ID: 29206090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, Histological, and Molecular Markers Associated With Allograft Loss in Transplant Glomerulopathy Patients.
    Kamal L; Broin PÓ; Bao Y; Ajaimy M; Lubetzky M; Gupta A; de Boccardo G; Pullman J; Golden A; Akalin E
    Transplantation; 2015 Sep; 99(9):1912-8. PubMed ID: 25675205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection.
    Zhang W; Yi Z; Keung KL; Shang H; Wei C; Cravedi P; Sun Z; Xi C; Woytovich C; Farouk S; Huang W; Banu K; Gallon L; Magee CN; Najafian N; Samaniego M; Djamali A; Alexander SI; Rosales IA; Smith RN; Xiang J; Lerut E; Kuypers D; Naesens M; O'Connell PJ; Colvin R; Menon MC; Murphy B
    J Am Soc Nephrol; 2019 Aug; 30(8):1481-1494. PubMed ID: 31278196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol biopsies in kidney transplant recipients: histologic findings as prognostic markers for graft function and outcome.
    Masin-Spasovska J; Spasovski G; Dzikova S; Grcevska L; Petrusevska G; Lekovski Lj; Popov Z; Ivanovski N
    Transplant Proc; 2005 Mar; 37(2):705-8. PubMed ID: 15848508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Rejection Gene Expression Score in Indication and Surveillance Biopsies Is Associated with Graft Outcome.
    Chamoun B; Caraben A; Torres IB; Sellares J; Jiménez R; Toapanta N; Cidraque I; Gabaldon A; Perelló M; Gonzalo R; O'Valle F; Moreso F; Serón D
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of T Cell-Mediated Vascular Rejection After Kidney Transplantation by the Combined Measurement of 5 Specific MicroRNAs in Blood.
    Matz M; Fabritius K; Lorkowski C; Dürr M; Gaedeke J; Durek P; Grün JR; Goestemeyer A; Bachmann F; Wu K; Rudolph B; Schmidt D; Weber U; Haftmann C; Unterwalder N; Lachmann N; Radbruch A; Neumayer HH; Mashreghi MF; Budde K
    Transplantation; 2016 Apr; 100(4):898-907. PubMed ID: 26444957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies.
    Halloran PF; Reeve JP; Pereira AB; Hidalgo LG; Famulski KS
    Kidney Int; 2014 Feb; 85(2):258-64. PubMed ID: 23965521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolution of untreated borderline and subclinical rejections at first month kidney allograft biopsy in comparison with histological changes at 6 months protocol biopsies.
    Masin-Spasovska J; Spasovski G; Dzikova S; Petrusevska G; Dimova B; Lekovski Lj; Popov Z; Ivanovski N; Polenakovic M
    Prilozi; 2005 Aug; 26(1):25-33. PubMed ID: 16118612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and Functional Noninvasive Immune Monitoring in the ESCAPE Study for Prediction of Subclinical Renal Allograft Rejection.
    Crespo E; Roedder S; Sigdel T; Hsieh SC; Luque S; Cruzado JM; Tran TQ; Grinyó JM; Sarwal MM; Bestard O
    Transplantation; 2017 Jun; 101(6):1400-1409. PubMed ID: 27362314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-activation gene expression in clinically stable renal allograft biopsies: molecular evidence for subclinical rejection.
    Lipman ML; Shen Y; Jeffery JR; Gough J; McKenna RM; Grimm PC; Rush DN
    Transplantation; 1998 Dec; 66(12):1673-81. PubMed ID: 9884258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of patients with Banff borderline changes in renal allograft biopsies.
    El-Agroudy AE; Wafa EW; Abbas TM; El-Husseini A; Gheith OA; El-Baz M; Ghoneim MA
    Exp Clin Transplant; 2009 Dec; 7(4):228-32. PubMed ID: 20353372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the activating cytotoxicity receptor NKG2D as a senescence marker in zero-hour kidney biopsies is indicative for clinical outcome.
    Günther J; Resch T; Hackl H; Sattler A; Ebner S; Ritschl PV; Biebl M; Öllinger R; Schneeberger S; Brandacher G; Schwelberger H; Zelger B; Stauch D; Pascher A; Pratschke J; Kotsch K
    Kidney Int; 2017 Jun; 91(6):1447-1463. PubMed ID: 28233611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic allograft nephropathy (CAN) in early renal protocol biopsies: does treatment of borderline and subclinical acute rejections prevent development and progression of CAN?
    Masin-Spasovska J; Spasovski G; Polenaković M; Dzikova S; Petrusevska G; Dimova B; Lekovski Lj; Popov Z; Ivanovski N
    Prilozi; 2005 Dec; 26(2):91-103. PubMed ID: 16400232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential predictive markers in protocol biopsies for premature renal graft loss.
    Matl I; Hribova P; Honsova E; Brabcova I; Viklicky O
    Kidney Blood Press Res; 2010; 33(1):7-14. PubMed ID: 20090361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histogenomics: association of gene expression patterns with histological parameters in kidney biopsies.
    Perco P; Kainz A; Wilflingseder J; Soleiman A; Mayer B; Oberbauer R
    Transplantation; 2009 Jan; 87(2):290-5. PubMed ID: 19155987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histologic findings in protocol biopsies of transplanted kidneys].
    Tichý T; Tichý M; Zadrazil J; Krejcí K; Horcicka V; al-Jabry S; Bachleda P; Král V; Dusek J
    Cesk Patol; 2003 Jan; 39(1):11-6. PubMed ID: 12673937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months.
    Scherer A; Gwinner W; Mengel M; Kirsch T; Raulf F; Szustakowski JD; Hartmann N; Staedtler F; Engel G; Klupp J; Korn A; Kehren J; Haller H
    Nephrol Dial Transplant; 2009 Aug; 24(8):2567-75. PubMed ID: 19398767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection.
    Sis B; Halloran PF
    Curr Opin Organ Transplant; 2010 Feb; 15(1):42-8. PubMed ID: 20009933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors associated with the deterioration of renal function: the role of protocol biopsies.
    Serón D
    Prilozi; 2007 Jul; 28(1):291-302. PubMed ID: 17932475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.